What is Entera Bio Ltd (ENTX) stock price today?

Entera Bio Ltd (ENTX) currently trades at $1.19 per share. The stock has a market capitalization of $60.98M and a P/E ratio of —x.

Is ENTX stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Entera Bio Ltd has a Smart Value Score of 17/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Entera Bio Ltd's revenue and earnings?

Entera Bio Ltd has trailing twelve-month (TTM) revenue of $42000.00 with profit margins of 0.00%. Earnings per share (EPS) is $-0.25.

ENTX

Entera Bio Ltd

NASDAQ: ENTX · HEALTHCARE · BIOTECHNOLOGY

$1.19

+6.25% today

Updated 2026-04-30

Market cap

$60.98M

P/E ratio

—

P/S ratio

1,452.00x

EPS (TTM)

$-0.25

Dividend yield

—

52W range

$1 – $3

Volume

0.2M

Market cap

$60.98M

P/E ratio

—

P/S ratio

1,452.00x

EPS (TTM)

$-0.25

Dividend yield

—

52W range

$1 – $3

Volume

0.2M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

2.7

Growth

5.0

Quality

C+

2.5

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →201 stocks currently score above 75

Price targets

Analyst target

$10.00

+740.34%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-2.05M

- Revenue declining -100.00% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$134000.00	$14000.00	$181000.00	$42000.00	$42000.00
Net income	$-13.07M	$-8.89M	$-9.54M	$-11.44M	$-3.02M
EPS	—	—	—	—	$-0.25
Free cash flow	$-12.55M	$-7.33M	$-6.82M	$-7.48M	$-2.05M
Profit margin	-9,754.48%	-63,492.86%	-5,271.27%	-27,235.71%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
ENTX	$60.98M	17	2.7	2.5	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Entera Bio Ltd trades at $1.19. Our Smart Value Score of 17/100 indicates the stock is weak. TTM revenue stands at $42000.00.

Frequently asked questions

What is Entera Bio Ltd's stock price?

Entera Bio Ltd (ENTX) trades at $1.19.

Is Entera Bio Ltd overvalued?

Smart Value Score 17/100 (Grade F, Strong Sell).

What is the price target of Entera Bio Ltd (ENTX)?

The analyst target price is $10.00, representing +740.3% upside from the current price of $1.19.

What is Entera Bio Ltd's revenue?

TTM revenue is $42000.00.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio1,452.00x

ROE-108.00%

Beta1.54

50D MA$1.28

200D MA$1.84

Shares out0.05B

Float0.03B

Short ratio—

Avg volume0.2M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

ENTX vs LLY →ENTX vs JNJ →ENTX vs ABBV →Stock screener →